Our research suggests that when applied alone or in combination with irradiation, PACAP38 can upregulate the expression of SOX6 by acetylating histones and suppressing the Wnt-β-catenin signaling to exert inhibitory impact on glioma and breast cancer cells. Here, SOX6 is linked to breast cancer.